Literature DB >> 12670328

Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors.

Julio Delgado1, Victor Jimenez-Yuste, Fernando Hernandez-Navarro, Ana Villar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12670328     DOI： 10.1046/j.1365-2141.2003.04162.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  90 in total

1.  Acquired factor VIII haemophilia following influenza vaccination.

Authors:  Guillaume Moulis; Grégory Pugnet; Haleh Bagheri; Claire Courtellemont; Antoine Huart; Dominique Chauveau; Jacques Pourrat; Jean-Louis Montastruc
Journal:  Eur J Clin Pharmacol       Date:  2010-06-27       Impact factor: 2.953

Review 2.  Clinical uses of intravenous immunoglobulin.

Authors:  S Jolles; W A C Sewell; S A Misbah
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

3.  Acquired haemophilia heralded by bleeding into the oral mucosa in a patient with bullous pemphigoid, rheumatoid arthritis, and vitiligo.

Authors:  R S Patel; K E Harman; C Nichols; R M Burd; S Pavord
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

Review 4.  Intravenous immunoglobulin: an update on the clinical use and mechanisms of action.

Authors:  Vir-Singh Negi; Sriramulu Elluru; Sophie Sibéril; Stéphanie Graff-Dubois; Luc Mouthon; Michel D Kazatchkine; Sébastien Lacroix-Desmazes; Jagadeesh Bayry; Srini V Kaveri
Journal:  J Clin Immunol       Date:  2007-03-11       Impact factor: 8.317

5.  Cautions and caveats to the treatment of acquired hemophilia A.

Authors:  Angela Huth-Kühne
Journal:  Haematologica       Date:  2009-08       Impact factor: 9.941

6.  Successful response to rituximab in two cases of acquired haemophilia refractory to standard-therapy.

Authors:  P Machado; J M Raya; T Martín; L Morabito; M L Brito; J M Rodríguez-Martín
Journal:  Int J Hematol       Date:  2008-04-15       Impact factor: 2.490

Review 7.  Autoantibodies with enzymatic properties in human autoimmune diseases.

Authors:  Bharath Wootla; Sébastien Lacroix-Desmazes; Arthur E Warrington; Allan J Bieber; Srini V Kaveri; Moses Rodriguez
Journal:  J Autoimmun       Date:  2011-05-31       Impact factor: 7.094

8.  Acquired hemophilia A.

Authors:  Yadav Pandey; Dinesh Atwal; Manojna Konda; Arya Roy; Appalanaidu Sasapu
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-11-20

Review 9.  Immune response to FVIII in hemophilia A: an overview of risk factors.

Authors:  Kanjaksha Ghosh; Shrimati Shetty
Journal:  Clin Rev Allergy Immunol       Date:  2009-10       Impact factor: 8.667

10.  Acquired haemophilia A as a blood transfusion emergency.

Authors:  Giuseppe Tagariello; Roberto Sartori; Paolo Radossi; Renzo Risato; Giovanni Roveroni; Cristina Tassinari; Annachiara Giuffrida; Giorgio Gandini; Massimo Franchini
Journal:  Blood Transfus       Date:  2008-01       Impact factor: 3.443
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.